Our Commitment to Corporate Ethics
In all our activities we are committed to the highest ethical and moral standards.
Corporate Ethics Take Priority over Profit
With the launch of the new Chugai in October of 2002, management issued a new basic philosophy that corporate ethics take priority over profit, a message that continues to be communicated today and that is shared among all employees. In working to achieve its Mission Statement, exemplifying a company that fulfills its responsibilities to society and responds to the expectations of its stakeholders, Chugai has established the Chugai Business Conduct Guidelines (Chugai BCG), and regularly reviews and revises its content in accordance with societal changes.
Chugai places paramount importance on respect for life and strives for fair and transparent corporate activities based on high ethical standards, along with sincere scientific initiatives. Specifically, through corporate ethics training and other programs, all Chugai employees share the Core Values of the Company. They understand the ethical standards necessary to execute the business of a healthcare company and follow those standards every day, based on the guidance of the Chugai BCG.
Commitment to Ethical Corporate Activities
The foreword to the IFPMA Code of Practice begins, “Advancing medical knowledge and improving global public health depend on information-sharing interactions by the entire medical community—from researcher to attending physician and nurse to patient—and integrity is essential to these exchanges. Fundamentally, there must always be confidence that prescription decisions are made on an ethical and patient-focused basis.”
The Chugai Group is a proactive participant in the Fair Trade Council of the Ethical Pharmaceutical Drugs Marketing Industry, the entity which administers the pharmaceutical industry’s voluntary guidelines, and in the Code Committee of the Japan Pharmaceutical Manufacturers Association. We have also established our own Chugai Code of Practice, and we promote ethical corporate behavior not only in our promotional activities, but also in the interactions between all of our officers and employees with researchers, medical professionals and patient groups.
Creating a Corporate Culture of Respect for Self and Others
The keyword can be translated into English as, “You can respect others if you can respect yourself.”
Among the guidelines for conduct included in the Chugai BCG are items that emphasize the importance of respect for human rights and promotion of diversity. Chugai’s corporate culture is based on respect for self and others. It is a culture in which individual employees have strong self-esteem, and in which, as diverse individuals interact with one another, they recognize each other’s values and promote respect for diversity—in short, we work to create workplaces that are free from harassment and infringement of human rights, and where co-workers value each other.
A corporate culture that respects human rights allows diverse individuals to make the most of their capabilities, thus improving performance. Moreover, by raising awareness of human rights and by promoting respect for diversity within Chugai, such a culture helps eliminate discrimination and infringement of human rights in the broader society as Chugai interacts with the public and through the everyday lives of its people.
Creating Workplaces Free from Harassment
Chugai strives to foster respect for diverse personalities and values, to create workplaces where both male and female employees can work with enthusiasm and peace of mind. To prevent sexual harassment and power harassment (abuse of power) in the workplace, we take various measures to educate employees and raise their awareness about these issues, including distributing a sexual harassment prevention handbook to every employee, and working from a handbook on creating workplaces free from power harassment in training for managers. We have also established a harassment hotline in the Corporate Social Responsibility Department, enabling employees to discuss their concerns freely, and have assigned area counselors at each branch, plant, and research laboratory, giving employees someone familiar with whom they can consult. Harassment consultation training by outside instructors and harassment hotline personnel is provided regularly for these area counselors and human resource managers to reinforce the knowledge and skills necessary to respond to calls.
In October 2012, we established a definition of power harassment at Chugai, as well as basic policies and regulations to prevent it. Since then, we have been conducting power harassment prevention workshops for managers in each department. This is one of the practical measures we take to foster harassment-free workplaces where people can work with enthusiasm.
Conduct of Clinical Trials
Clinical trials are essential for verifying the safety and efficacy of investigational products, and they must be performed with respect for the rights of trial subjects. At Chugai, clinical trials are closely monitored for patient safety, following stringent scientific methodology based on the highest ethical standards.
The Chugai Group is committed to evaluating the real merit of investigational products using well-established, reputable testing procedures that comply with Japan’s PMD Act and other related legislation, as well as the current revision of the Declaration of Helsinki*1 and ICH-GCP*2 which are global standards.
Protocol Review Committee
Before the start of a proposed clinical trial, the Protocol Review Committee, which includes members from outside Chugai, checks the protocol to ensure that it is ethically and scientifically sound. The protocol is then checked by a governmental regulatory agency, before being carefully examined by an Institutional Review Board composed of medical professionals and impartial members at medical institutions. They each make decisions on whether or not Chugai may proceed with a given trial.
Standard Operating Procedures
Clinical trials are undertaken in compliance with specific Standard Operating Procedures (SOPs) prepared and updated by Chugai. Chugai’s SOPs comply with all applicable pharmaceutical laws and regulations.
Safety Evaluation Committee
Whenever obtaining important information on safety of investigational products from clinical trials, Chugai promptly gathers the needed information, and then analyzes and deliberates on it in a Safety Evaluation Committee composed of medical and scientific experts including physicians. This ensures that patient welfare always remains the highest priority throughout the meticulous process of sharing information with regulatory authorities and the medical institutions involved.
*1.The “Ethical Principles for Medical Research Involving Human Subjects” first adopted at the World Medical Association in 1964. Biomedical research must ultimately include testing on human subjects in order to contribute to healthcare. The 1964 Declaration of Helsinki is the ethical foundation of modern clinical trials. (Source: The Pharmaceutical Society of Japan)
*2.Good Clinical Practice (GCP) guidelines adopted by the International Conference on Harmonisation (ICH) for conducting pharmaceutical clinical trials in the European Union, the United States and Japan.
(Source: The Pharmaceuticals and Medical Devices Agency)